<span item_type="fundamental" item_id="25cff908e2d2bce8c62e7846640a4694" counter_id="ST/US/AIMUF" env="prod"></span><span item_type="announcement" item_id="596945030598559105" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -248.88 K.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Interest Earned on Cash and Investments Held in Trust Account</strong>: $630,505 for the nine months ended September 30, 2025, compared to $1,603,118 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: $117,673 for the nine months ended September 30, 2025, compared to $902,163 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li><li><strong>Formation and Operating Costs</strong>: $512,832 for the nine months ended September 30, 2025, compared to $700,955 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: - $365,189 for the nine months ended September 30, 2025, compared to - $480,681 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li><li><strong>Net Cash Provided by Investing Activities</strong>: $23,276,164 for the nine months ended September 30, 2025, compared to $9,069,945 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li><li><strong>Net Cash Used in Financing Activities</strong>: - $22,912,353 for the nine months ended September 30, 2025, compared to - $8,589,358 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Ordinary Shares Subject to Possible Redemption</strong>: $14,294,569 as of September 30, 2025, compared to $36,940,228 as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to complete its initial business combination by the extended deadline of December 28, 2025, with the possibility of further extensions up to July 28, 2026, by depositing $500 for each one-month extension into the Trust Account.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li><li><strong>Non-Core Business</strong>: The company has entered into various agreements to convert outstanding loans into equity, including a conversion of $1,500,000 of promissory notes into 150,000 private units as part of the transaction financing for the business combination with Docter Inc.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1903464/000121390025125447/ea0268841-10q_aimfinity1.htm"></span></li></ul>

AIMFINITY INVESTMENT CORP I UT 1A&1WT CL1 EX & 1/2WT CL2 EX 01/02/29 | 10-Q: FY2025 Q3 Revenue: USD 0